TNXP Stock Analysis: Buy, Sell, or Hold?
TNXP - Tonix Pharmaceuticals Holding Corp.
$15.74
1.65 (11.71%)
▲
5d:
+11.71%
30d:
+11.39%
90d:
+3.96%
WAIT
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 18, 2026
0d
Smart Money Accumulation
TNXP is down 5.8% this week, but smart money is accumulating calls. Top strike: $17.5 2026-06-18 with 460 OI. Call ratio: 78% View Scanner →
Strength: 5.7/10
Get Alerted When TNXP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
21 traders called TNXP this week
89% bullish • 4 bearish
89% bullish • 4 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: TNXP is 10.2% above its trading range ($14.28). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: TNXP is 10.2% above its trading range ($14.28). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: TNXP is currently trading at $15.74, which is considered extended relative to its 30-day fair value range of $12.74 to $14.28.
Technical Outlook: Technically, TNXP is in a strong downtrend. The price is approaching resistance at $15.18. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 11.7% recently.
Market Sentiment: TNXP has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $46.25 (+193.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TNXP is in a strong downtrend. The price is approaching resistance at $15.18. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 11.7% recently.
Market Sentiment: TNXP has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $46.25 (+193.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$12.74 -
$14.28
Company Quality Score
57/100
(HOLD)
Options IV Signal
31th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
60.4%
All Signals
- BEARISH: Price significantly overextended (+10.2% above its trading range)
- NEUTRAL: Options fairly priced (IV 31th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+11.7%)
- BULLISH: Trading 193.8% below Wall St target ($46.25)
- WARNING: Recommendation downgraded due to 10.2% overvaluation
Trading Range Analysis
30-Day Trading Range
$12.74 -
$14.28
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$3.27
(20.7%)
Support & Resistance Levels
Support Level
$12.52
Resistance Level
$15.18
Current Trend
Strong Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.05
Wall Street Target
$46.25
(+193.8%)
Revenue Growth (YoY)
183.2%
Share & Embed Analysis
Last updated: May 18, 2026 8:30 AM ET
Data refreshes hourly during market hours. Next update: 9:30 AM
Data refreshes hourly during market hours. Next update: 9:30 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TNXP showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Seth Lederman
BUY
15000 shares
2026-03-18
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$90 | 60 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$101 | 58 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$30 | 59 HOLD |
|
BHVN
Biohaven Pharmaceutical … |
STRONG BUY
16 analysts |
$22 | 57 HOLD |
